Evidence map›Paper›PMID 41226732›Full record

ReviewInternational journal of molecular sciences2025

Aerogels Part 2. A Focus on the Less Patented and Marketed Airy Inorganic Networks Despite the Plethora of Possible Advanced Applications.

Silvana Alfei

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Silvana AlfeiDepartment of Pharmacy (DIFAR), University of Genoa, Viale Cembrano, 4, 16148 Genoa, Italy.ORCID 0000-0002-4630-4371

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, the state of the art of aerogels (AGs) has been reviewed, reporting first on their classification, based on the chemical origin of their precursors and the different methods existing to prepare them. Additionally, AGs of inorganic origin (IAGs) were contemplated, deeply discussing the properties, specific synthesis, and possible uses of silica and metal oxide-based AGs, since they are the most experimented and patented AGs already commercialized in several sectors. In this second part review, IAGs are examined again, but chalcogenide and metals AGs (CAGs and MAGs) are debated, since they are still too little studied, patented, and marketed, despite their nonpareil properties and vast range of possible applications. First, to give readers unaware of the previous work on AGs, a background about IAGs, all their main subclasses have been reported and their synthesis, including sol-gel, epoxide addition (EA), and dispersed inorganic (DIS) methods, as well as procedures involving the use of pre-synthesized nanoparticles as building blocks, have been discussed. Morphology and microstructure images of materials prepared by such synthetic method have been supplied. Conversely, the methods needed to prepare CAGs and MAGs, topics of this study, have been debated separately in the related sections, with illustrative SEM images. Their possible uses, properties, and some comparisons of their performance with that of other AGs and not AG materials traditionally tested for the same scopes, have also been disserted, reporting several case studies in reader-friendly tables.

Indexed as

GelsMetalsOxidesPatents as TopicSilicon DioxideGelsMetalsOxidesSilicon Dioxideaerogels (AGs)chalcogenide AGsinorganic-based AGsmetal AGsnoble metal AGsnot sol–gel routessol–gel synthesistemplating methods

Identifiers

PMID41226732
PMCPMC12608421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.